This content is from: Premium Glenview Takes a Loss But Larry Robbins’ two main funds are still solidly beating the S&P 500. By Stephen Taub March 02, 2023
This content is from: Premium Glenview Posts Huge January Gains Many of the month’s biggest winners were last year’s biggest losers. By Stephen Taub February 02, 2023
This content is from: Premium Glenview Posts Mixed Results in 2022 One of the firm’s main funds made money, while the other lost less than half what the S&P 500 did. By Stephen Taub January 09, 2023
This content is from: Premium Another Round of Gains for Glenview One fund is solidly in the black, while another is getting there. By Stephen Taub December 06, 2022
This content is from: Premium Glenview Rebounds in October One of the firm’s funds has even climbed back into the black for the year. By Stephen Taub November 02, 2022
This content is from: Premium Glenview Extends Losses in September The firm’s healthcare stocks took a hit, but still outperformed Glenview’s other holdings. By Stephen Taub October 05, 2022
